Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q1 2023 Earnings Call Transcript May 11, 2023
Acorda Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.69, expectations were $-1.56.
Operator: Welcome to Acorda Therapeutics First Quarter 2023 Financial and Business Update. [Operator Instructions]. Please be advised that this call is being recorded at the company’s request. I will now introduce your host for today’s call, Tierney Saccavino at Acorda. Tierney, please go ahead.
Tierney...
